We are live on ! Find out more
GTHX

G1 Therapeutics, Inc. Common Stock
GTHX

Delisted

GTHX was delisted on the 17th of September, 2024.

Back to rankings

108 hedge funds and large institutions have $270M invested in G1 Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 41 increasing their positions, 35 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 35

5% less call options, than puts

Call options by funds: $1.07M | Put options by funds: $1.13M

6% less funds holding

Funds holding: 115 → 108 (-7)

24% less capital invested

Capital invested by funds: $358M → $270M (-$87.4M)

33% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 18

Holders
108
Holders Change
-7
Holders Change %
-6.09%
% of All Funds
1.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
41
Reduced
35
Closed
18
Calls
$1.07M
Puts
$1.13M
Net Calls
-$60K
Net Calls Change
-$394K

Top Buyers

Rank Fund Capital Flow
1
Fisher Asset Management
Fisher Asset Management
Washington
+$6.75M
2
Citadel Advisors
Citadel Advisors
Florida
+$3.16M
3
CA
CHI Advisors
New York
+$2.29M
4
UBS Group
UBS Group
Switzerland
+$1.75M
5
Rafferty Asset Management
Rafferty Asset Management
New York
+$1.74M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$8.77M
2
Goldman Sachs
Goldman Sachs
New York
-$3.87M
3
Voloridge Investment Management
Voloridge Investment Management
Florida
-$2.65M
4
TCM
Tekla Capital Management
Massachusetts
-$2.56M
5
Russell Investments Group
Russell Investments Group
United Kingdom
-$2.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Advisers
26
Two Sigma Advisers
New York
$2.34M -$1.4M -109,800 -32%
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
$2.03M +$437K +34,290 +21%
Two Sigma Investments
28
Two Sigma Investments
New York
$1.39M +$656K +51,504 +61%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$1.33M +$60.1K +4,719 +4%
NIM
30
Needham Investment Management
New York
$1.17M +$338K +26,500 +30%
Fidelity Investments
31
Fidelity Investments
Massachusetts
$1.13M -$8.77M -688,161 -86%
Ameriprise
32
Ameriprise
Minnesota
$1.02M -$280K -21,996 -18%
Wellington Management Group
33
Wellington Management Group
Massachusetts
$950K +$1.19M +93,078 New
SFI
34
Susquehanna Fundamental Investments
Pennsylvania
$902K +$488K +38,310 +77%
Barclays
35
Barclays
United Kingdom
$669K +$622K +48,788 +292%
Swiss National Bank
36
Swiss National Bank
Switzerland
$659K – – –
Millennium Management
37
Millennium Management
New York
$659K +$823K +64,564 New
Wells Fargo
38
Wells Fargo
California
$587K -$623K -48,918 -46%
JAM
39
Jupiter Asset Management
United Kingdom
$527K -$138K -10,861 -18%
RJFSA
40
Raymond James Financial Services Advisors
Florida
$513K +$114K +8,949 +22%
Jane Street
41
Jane Street
New York
$511K -$188K -14,780 -23%
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$481K +$828 +65 +0.1%
SG Americas Securities
43
SG Americas Securities
New York
$476K -$164K -12,907 -22%
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$472K +$11.5K +905 +2%
State of Wisconsin Investment Board
45
State of Wisconsin Investment Board
Wisconsin
$469K – – –
GG
46
Golden Green
South Carolina
$424K -$273K -21,432 -34%
UBS AM
47
UBS AM
Illinois
$419K – – –
BC
48
Birchview Capital
Vermont
$408K – – –
BNP Paribas Financial Markets
49
BNP Paribas Financial Markets
France
$402K +$403K +31,611 +407%
BWA
50
BDO Wealth Advisors
Florida
$360K – – –
1
2
3 4 5

GTHX Hedge Fund Activity: Q4 2021 in Review

108 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in G1 Therapeutics, Inc. Common Stock (GTHX) for Q4 2021, worth a combined $270M — down 24% from $358M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of GTHX and 12 opened new positions — a net loss of 6 holders — while 35 trimmed existing stakes and 41 added.

The largest buyer was Fisher Asset Management, adding an estimated $6.75M. The largest seller was Fidelity Investments, cutting an estimated $8.77M.

  • 108 institutional investors held G1 Therapeutics, Inc. Common Stock (GTHX) as of Q4 2021, down from 115 in Q3 2021.
  • Funds reported $270M of G1 Therapeutics, Inc. Common Stock stock for Q4 2021, down 24% quarter-over-quarter.
  • 12 funds opened new G1 Therapeutics, Inc. Common Stock positions in Q4 2021 and 18 closed out, a net change of -6 holders.
  • The largest G1 Therapeutics, Inc. Common Stock buyer in Q4 2021 was Fisher Asset Management, an estimated $6.75M added.
  • The largest G1 Therapeutics, Inc. Common Stock seller in Q4 2021 was Fidelity Investments, an estimated $8.77M sold.

Based on aggregated 13F filings for Q4 2021.